Merck To Pay $80M To Settle Vioxx Suits
Merck described the settlement, which had not been previously disclosed, in a filing Monday with the U.S. Securities and Exchange Commission.
A representative of Merck said the company would have no further comment beyond the SEC filing.
According to the filing, the 190 claims by individual third-party payors are pending in the Superior Court of New Jersey...
To view the full article, register now.